Bastos F, Cross JH. Epilepsy. Handb Clin Neurol. 2020;174:137–58.
Guerrini R. Epilepsy in children. Lancet. 2006;367:499–524.
Fine A, Wirrell EC. Seizures in Children. Pediatr Rev. 2020;41:321–47.
Carney P, Prowse MA, Scheffer IE. Epilepsy syndromes in children. Aust Fam Physician. 2005;34:1009–15.
Sharma P, Hussain A, Greenwood R. Precision in pediatric epilepsy. F1000Res. 2019;8:F1000.
Article PubMed PubMed Central Google Scholar
Striano P, Minassian BA. From genetic testing to precision medicine in epilepsy. Neurotherapeutics. 2020;17:609–15.
Article PubMed PubMed Central Google Scholar
Huang Y, et al. Variants in CAPZA2, a member of an F-actin capping complex, cause intellectual disability and developmental delay. Hum Mol Genet. 2020;29:1537–46.
Article PubMed PubMed Central Google Scholar
Pi S, et al. A de novo inframe deletion variant in CAPZA2 tentacle domain with global developmental delay and secondary microcephaly. Clin Genet. 2022;102:355–6.
Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Article PubMed PubMed Central Google Scholar
Narita A, et al. Structural basis of actin filament capping at the barbed-end: a cryo-electron microscopy study. EMBO J. 2006;25:5626–33.
Article PubMed PubMed Central Google Scholar
Zigmond SH. Beginning and ending an actin filament: control at the barbed end. Curr Top Dev Biol. 2004;63:145–88.
Pollard TD, Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell. 2003;112:453–65.
Weeds A, Maciver S. F-actin capping proteins. Curr Opin Cell Biol. 1993;5:63–9.
Wear MA, et al. How capping protein binds the barbed end of the actin filament. Curr Biol. 2003;13:1531–7.
Yamashita A, Maeda K, Maeda Y. Crystal structure of CapZ: structural basis for actin filament barbed end capping. EMBO J. 2003;22:1529–38.
Article PubMed PubMed Central Google Scholar
Hopmann R, Cooper JA, Miller KG. Actin organization, bristle morphology, and viability are affected by actin capping protein mutations in Drosophila. J Cell Biol. 1996;133:1293–305.
McEntagart M, et al. A restricted repertoire of de novo mutations in ITPR1 cause gillespie syndrome with evidence for dominant-negative effect. Am J Hum Genet. 2016;98:981–92.
Article PubMed PubMed Central Google Scholar
Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature. 1987;329:219–22.
Article ADS PubMed Google Scholar
Gerasimavicius L, Livesey BJ, Marsh JA. Loss-of-function, gain-of-function and dominant-negative mutations have profoundly different effects on protein structure. Nat Commun. 2022;13:3895.
Article ADS PubMed PubMed Central Google Scholar
Veitia RA, Caburet S, Birchler JA. Mechanisms of Mendelian dominance. Clin Genet. 2018;93:419–28.
Backwell L, Marsh JA. Diverse molecular mechanisms underlying pathogenic protein mutations: beyond the loss-of-function paradigm. Annu Rev Genomics Hum Genet. 2022;23:475–98.
Amberger JS, et al. OMIM.org: leveraging knowledge across phenotype-gene relationships. Nucleic Acids Res. 2019;47:D1038–D1043.
Rehm HL, et al. ClinGen—the clinical genome resource. N. Engl J Med. 2015;372:2235–42.
Article PubMed PubMed Central Google Scholar
Hart MC, Korshunova YO, Cooper JA. Vertebrates have conserved capping protein alpha isoforms with specific expression patterns. Cell Motil Cytoskeleton. 1997;38:120–32.
Jiang S, et al. Overexpression of CAPG is associated with poor prognosis and immunosuppressive cell infiltration in ovarian cancer. Dis Markers. 2022;2022:9719671.
留言 (0)